Literature DB >> 8943145

Subjective, laryngoscopic, and acoustic measurements of laryngeal reflux before and after treatment with omeprazole.

G Y Shaw1, J P Searl, J L Young, P B Miner.   

Abstract

Laryngeal manifestation of gastroesophageal reflux is felt to be prevalent in our society. In general, diagnosis has been based primarily on symptoms. Historically, additional testing included laryngoscopy, barium swallow, manometry, and more recently, single- and double-probe pH monitoring. We evaluated 68 patients who were symptomatically suggestive of having reflux laryngitis. We administered surveys grading their symptoms. All patients underwent standardized videolaryngostroboscopic evaluation and computerized acoustic analysis. Patients then underwent a uniform therapy of dietary restrictions and omeprazole, a hydrogen ion inhibitor, for 12 weeks. Patients were then retested. This regimen demonstrated an 85% success of relieving symptoms. Utilizing the new laryngoscopic grading system, improvement was found to be statistically significant in improvement of all findings except granulomas. In patients with the pretherapy complaint of hoarseness, acoustic measures of jitter, shimmer, habitual frequency, and frequency range all showed significant improvement. The authors conclude that in patients with symptomatic reflux laryngitis, standardized videolaryngoscopy and, if hoarse, acoustic analysis are useful exam techniques to aide diagnosis and monitor therapy. Anti-reflux therapy with omeprazole is effective and improvement can be objectively demonstrated with the techniques described.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943145     DOI: 10.1016/s0892-1997(96)80033-6

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  9 in total

1.  A 92-year-old woman with dyspnoea and stridor.

Authors:  K M Ban; L D Sanchez; K Bramwell; J C Sakles; D Davis; R Wolfe; P Rosen
Journal:  Intern Emerg Med       Date:  2007-06       Impact factor: 3.397

Review 2.  Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments.

Authors:  Kornilia Nikaki; Philip Woodland; Daniel Sifrim
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-27       Impact factor: 46.802

3.  Gender differences in the presentation of dysphonia related to laryngopharyngeal reflux disease: a case-control study.

Authors:  Jérôme R Lechien; Kathy Huet; Mohamad Khalife; Anne-Françoise Fourneau; Camille Finck; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-26       Impact factor: 2.503

Review 4.  Supra-oesophageal manifestations of gastro-oesophageal reflux disease.

Authors:  Manuel Rodríguez-Téllez
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Pharyngeal pH monitoring in 222 patients with suspected laryngeal reflux.

Authors:  T R Eubanks; P E Omelanczuk; N Maronian; A Hillel; C E Pope; C A Pellegrini
Journal:  J Gastrointest Surg       Date:  2001 Mar-Apr       Impact factor: 3.452

6.  Laryngopharyngeal reflux: Current opinion.

Authors:  K K Handa
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2005-07

7.  Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice.

Authors:  Vicente Garrigues; Lirios Gisbert; Guillermo Bastida; Vicente Ortiz; Inmaculada Bau; Pilar Nos; Julio Ponce
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

8.  Self-Perception of Swallowing-Related Problems in Laryngopharyngeal Reflux Patients Diagnosed with 24-Hour Oropharyngeal pH Monitoring.

Authors:  Tamer A Mesallam; Mohamed Farahat
Journal:  Biomed Res Int       Date:  2016-02-04       Impact factor: 3.411

9.  Laryngeal and vocal analysis in bulimic patients.

Authors:  Cynthia P Ferreira; Ana Cristina Côrtes Gama; Marco Aurélio Rocha Santos; Mariana Oliveira Maia
Journal:  Braz J Otorhinolaryngol       Date:  2010 Jul-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.